Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Merck Rises 11% YTD: Should Investors Buy, Sell or Hold the Stock?
Merck Rises 11% YTD: Should Investors Buy, Sell or Hold the Stock?

Merck’s MRK stock has risen 11% so far this year. Merck’s strong financial performance, positive clinical data, and improving sentiment about the future are some of the key factors driving the stock